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ABSTRACT
Cytokines are molecules that act as mediators of immune response; cerebral spinal fluid (CSF) IL-6 is 
found in all meningeal inflammatory diseases, but IL-8 is associated with acute bacterial meningitis 
(ABM). A case control study was done to ascertain the discriminatory power of these cytokines in 
differentiating ABM from aseptic meningitis (AM); IL-6 and IL-8 CSF concentrations were tested 
through ELISA in samples collected from patients who underwent investigation for meningitis. Sixty 
patients, 18 with AM, nine with bacteriologic confirmed ABM and 33 controls, assisted in 2005 (MA 
and controls) and 2007 (ABM) were included. Differently from controls, IL-6 concentrations were 
increased both in MA and ABM patients (p < 0.05). CSF IL-8 levels were higher in ABM than in AM 
and controls (p < 0.05). Discriminatory power in ABM as assessed by the area under receiver opera-
tor (ROC) curve was 0.951 for IL-8, using a cut-off of 1.685 ng/dL (100% of sensitivity and 94% of 
specificity). The CSF concentration of both IL-6 and IL-8 are increased in the presence of meningeal 
inflammation, IL-8 could be an important tool to differentiate ABM from AM.
Keywords: CSF; inflammation meningitis; aseptic meningitis; bacteria; IL-6; IL-8.
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INTRODUCTION
Cytokines are molecules involved in the modu-
lation of immune and inflammatory processes. 
Interleukin-6 (IL-6) is a cytokine of both in-
nate and adaptive immunity and exerts diverse 
actions. The main cellular action of IL-6 is to 
stimulate the growth of B lymphocytes which 
have differentiated into antibody producing 
cells. Interleukin-8 (IL-8) acts as chemoattract-
ant for neutrophils to the site of inflammation.1
Elevated CSF cytokine levels are undisput-
ed markers of meningeal inflammation,2 but a 
specific profile of cytokine concentration for 
differential diagnostic purposes is not yet avail-
able. CSF levels of IL-6 are indiscriminately el-
evated in all kinds of meningitis,3 and do not 
contribute to this purpose. Some studies that 
measured CSF IL-8 concentrations found high 
levels of this chemokine associated mainly 
with bacterial meningitis, but its role in aseptic 
meningitis remains elusive.4,5
Differentiation between aseptic meningitis 
and acute bacterial meningitis (ABM) in some 
instances can be puzzling. The search for clini-
cal markers and laboratory tests to help in this 
task is crucial in order to optimize the treat-
ment of these conditions. A suitable diagnostic 
tool has been pursued for many years, but until 
now little has been added to clinical practice.6-8 
The importance of an early differentiation 
between these two conditions resides in the 
choice of the proper treatment regimen and in 
the need for inpatient care, especially in ABM, 
which has a poor prognosis if left untreated.
The aim of our study was to measure CSF 
IL-6 and IL-8 in patients with aseptic meningi-
tis, bacterial meningitis and normal controls in 
order to investigate these cytokines as potential 
tools in the differential diagnosis of bacterial 
meningitis from aseptic meningitis.
PATIENTS AND METHODS
We performed a case-control study with CSF 
samples from patients assisted in Instituto Es-
tadual de Infectologia São Sebastião (IEISS), 
the referral center for infectious diseases in 
Rio de Janeiro State. AM and control sam-
ples were collected during the year of 2005, 
whereas ABM CSF samples were collected 
in 2007. Sixty patients were selected, 18 had 
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aseptic meningitis, nine had confirmed laboratorial diag-
nosis of meningitis caused by Neisseria meningitidis, and 
33 had no meningitis (controls). The diagnostic criteria for 
aseptic meningitis were CSF total leukocyte count above 
five cells, negative bacteriological tests and a clinical con-
dition compatible with meningitis. Patients with bacterial 
meningitis were selected on the grounds of a positive CSF 
culture or a reactive latex for N. meningitidis. Controls were 
included if the CSF analyses were normal.
This study was designed according to Brazilian laws 
for research involving human beings and was approved 
by the Ethical Committee of Evandro Chagas Clinical 
Research Institute, FIOCRUZ, Rio de Janeiro.
CSF samples were selected by simple random sam-
pling from patients undergoing evaluation for meningi-
tis. No patient was submitted to lumbar puncture only 
for the purpose of collecting samples for the study. The 
CSF was analyzed for cellular content, protein and glu-
cose levels and bacteriological tests using laboratory 
routine methods. CSF was stored at –20oC and centri-
fuged for cytokine concentration measurement.
We performed IL-6 and IL-8 measurements from 
CSF samples by ELISA using specific monoclonal anti-
bodies (Duo set kit – R&D systems) according to the 
manufacturer’s instructions. The results were analyzed 
by Soft Max Pro software based on the concentrations of 
the standard curves of each assay.
Statistical analyses were performed using SPSS for 
Windows 13.0 (SPSS Inc., Chicago, IL, USA). Measure-
ments of central tendency and dispersion for continuous 
variables (median, standard deviation and range) were 
used and comparisons between them were tested using 
Mann-Whitney U-test. Receiver operating characteris-
tic curve (ROC) was computed, and the area under the 
ROC curve (AUROC) was used to evaluate the ability 
of IL-8 to discriminate bacterial meningitis from asep-
tic meningitis. The optimum cut-off was defined as the 
value that maximized the AUROC.
RESULTS
We analyzed 60 CSF samples; the demographical char-
acteristics, the results for routine CSF analysis and IL-6/
IL-8 assay results are shown in Table 1. The groups had no 
statistically significant difference in demographic aspects 
(p > 0.05), but they were different regarding CSF inflamma-
tory parameters (p < 0.05).
IL-6 concentrations were very similar between aseptic 
meningitis and bacterial meningitis cases, with no signifi-
cant difference (p > 0.05). Conversely, CSF IL-8 concentra-
tions were higher in the bacterial meningitis group with a 
significant difference when compared to the aseptic menin-
gitis group (p < 0.05). Both IL-6 and IL-8 concentrations in 
meningitis cases (aseptic and bacterial) were markedly dif-
ferent from the concentrations found in the CSF of patients 
in the control group (p < 0.05).
We calculated the area under the ROC curve to ana-
lyze the power of IL-8 to discriminate bacterial meningi-
tis from aseptic meningitis. IL-8 appeared as an excellent 
marker for differentiating ABM from AM (AUROC = 0.95, 
95% CI = 0.855 to 1.046; p < 0.05) when the cut-off level of 
1.685 ng/dL was used. At this cut-off, IL-8 had 100% sensi-
tivity and 94% specificity. AUROC for others CSF inflamma-
tory parameters are summarized in Table 2. 
Table 1. Demographic characteristics, CSF analysis and median IL6/IL8 concentrations of sixty patients  
assisted in IEISS (2005 and 2007)
Parameters Aseptic meningitis (n = 18) Bacterial meningitis (n = 9) Controls (n = 33)
Age (years) 8.0 (0.5 - 46) 13.1 (0.2 - 50.0) 5.4 (0.2 - 27.0)
Male sex (%) 50.0 66.7  63.6
Total cell count (leukocytes/mm3) 100 (10 - 600) 4677 (512 - 15,545) 1.1 (0 - 4)
Protein (mg/dL) 41.9 (20.0 - 200.0) 653.9 (55.0 - 1000.0) 24.6 (10.0 - 64.0)
Glucose (mg/dL) 58.8 (25.0 - 91.0) 17.6 (0 - 49.0) 58.1 (19.0 - 100.0)
IL-6 (ng/mL) 0.415 (0.177 - 0.636) 0.536 (0.231 - 0.622) 0.148 (0.047 - 0.640)
IL-8 (ng/mL) 0.662 (0.118 - 3.528) 2.464 (1.854 - 4.801) 0.055 (0.07 - 2.196)
Table 2 – AUROC for CSF IL-8, IL-6 and other inflam-
matory parameters (bacterial meningitis vs. aseptic 
meningitis)
CSF Parameter Area p 95% CI
IL-8 0.95 <0.05 0.855 - 1.046
IL-6 0.66 0.187 0.444 - 0.876
Leukocyte count 0.99 < 0.05 0.973 - 1.014
Glucose 0.04 < 0.05 0.028 - 0.106
Protein 0.98 < 0.05 0.939 - 1.022
95% CI, confidence interval; CSF, cerebrospinal fluid.
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DISCUSSION
In our study, we found that IL-6 and IL-8 are important 
inflammatory mediators in all cases with meningitis. CSF 
concentrations of these molecules in meningitis cases were 
significantly different when compared to the control group. 
Analyzing these mediators individually we found that CSF 
IL-8 concentration in ABM at the moment of diagnosis was 
markedly higher than in AM group (p < 0.05).
As a retrospective study performed in a referral center, 
selection bias is a possible methodological problem, but the 
different groups were comparable. Another possible limita-
tion was the lack of etiological diagnosis of AM cases, even 
without laboratorial evidence of bacterial involvement.
IL-6 concentrations were higher in both AM and ABM 
groups demonstrating that this molecule acts as mediator in 
meningeal inflammation, serving as a non-specific inflam-
matory marker.9 This is in agreement with other studies 
which also compared the levels of IL-6 in cases of bacterial 
and aseptic meningitis and did not find significant differenc-
es.3,10 CSF IL-8 measurement in these two types of meningi-
tis were performed in a study conducted by Lopez-Cortez 
et al. in 1995.4 Patients with bacterial meningitis had higher 
concentrations of this chemokine in CSF compared to AM 
cases. The authors suggested a cut-off of 2.5 ng/dL for CSF 
IL-8 concentration using only the dispersion graph for this 
concentration. Ostegaard et al. in 1996 conducted a study in 
which CSF IL-8 concentrations were also compared between 
these two groups of patients and controls concluding that 
IL-8 concentrations were higher in the ABM group. In our 
study we determined the value of 1.685 ng/dL as the best 
cut-off, performing a ROC curve, which is designed for this 
purpose. The accuracy of this cut-off was also excellent. It 
is important to note that cut-off values for IL-8 may vary 
depending on variations of the methodology or reagents 
used, and before standardized tests are available one must 
determine the specific cut-off value under the conditions 
employed to ensure the best accuracy.
In order to confirm whether the measurement of CSF 
IL-8 had the power to discriminate bacterial meningitis 
from aseptic meningitis, we have performed the AUROC 
for CSF protein level and total leukocyte count which are 
of indisputable importance in the differential diagnosis of 
acute meningitis. The AUROC evidenced that IL-8 had the 
same power of CSF protein, leukocyte count and glucose 
level. CSF IL-6 concentration showed little utility in this dif-
ferentiation.
The cost for cytokines determination in biological sam-
ples has decreased significantly over the past decade as 
availability has increased. In fact, it will probably decrease 
even further if measurements of cytokines become stand-
ard clinical analysis in the hospital setting. Importantly, IL-8 
measurements is not a substitute for CSF protein, glucose or 
leukocyte determinations, but rather an additional and use-
ful input information that may help diagnosis in cases where 
a clear diagnosis cannot be reached by standard techniques.
Differential diagnosis between aseptic and bacterial 
meningitis in some instances can be difficult. A trustworthy 
laboratory marker would facilitate the clinical decision of in-
terrupting antimicrobial therapy and avoiding unnecessary 
hospitalization. CSF IL-8 concentrations above 1.685 ng/dL 
would indicate bacterial meningitis confirming other clini-
cal and laboratory findings. More studies performed in suit-
able models of meningitis are needed in order to establish 
the routine use of inflammatory markers in the diagnosis of 
infectious diseases of the central nervous system.
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